Open AccessPembrolizumab Improves Survival in Advanced Liver Cancer
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000821992.51376.32
Subject(s) - sorafenib , pembrolizumab , medicine , hepatocellular carcinoma , placebo , liver cancer , oncology , cancer , population , adverse effect , immunotherapy , alternative medicine , pathology , environmental health